Observations on 73 Vaccine breakthrough COVID-19 infected patients and their individualized homeopathic treatment

ABSTRACT

Background: Since the initiation of vaccine rollout, breakthrough COVID-19 infections have been reported. While conventional therapy is the accepted mode of treatment, there has been little recognition of the role played by complementary therapies like homeopathy. The purposes of this study were to observe retrospectively the clinical-symptomatic profile of the vaccine breakthrough COVID-19 infections and their individualized homoeopathic treatment. Methods: Observations on the data of patients treated with homeopathic medicines who confirmed the breakthrough infection criteria, positive infection ≥14 days after completion of both the recommended doses of an authorized COVID-19 vaccine, were conducted. IBM SPSS Statistics 21.0 was used for descriptive data analysis. WHO Clinical Progression Scale and Outcome about Impact on Daily Living score were used to understand the results of treatment. Results: Out of the 1397 Covid-19 positive patients, a total of 73 cases were identified as vaccine breakthrough infections. The median recovery time reported in the data set was 9 ± 2 days. While 5 patients dropped out, 68 (93.15%) patients responded positively to homeopathic treatment, and 55 (75.34%) recovered completely with normalized serological markers/ nasal swabs/ HRCT Chest. About 29 (39.72%) of these presented with mild clinical manifestations, 26 (35.61%) moderate, 17 (23.28%) severe and 1 (1.36%) was critical. 10 homeopathic remedies were prescribed to these 73 patients. Majority of the patients attained an ORIDL score of 4. Maximum patients reported a WHO clinical Progression score of 3. Conclusion: This report compiles a clinical-symptomatic profile of vaccine breakthrough patients, which occurs in a fraction of vaccinated people, their anamnesis and response to individualized homeopathic treatment. Further exploratory research studies and comparative clinical trials may be encouraged. © 2022